AKT1 and osteosarcoma: Trichostatin A (TSA), a histone deacetylase inhibitor (HDACi), induces autophagy in osteosarcoma cells by suppressing the AKT-mTOR signaling pathway and activating FoxO1, thereby enhancing the survival of osteosarcoma cells.